Nanostics Company

Nanostics is a developer of diagnostics tests intended to diagnose aggressive prostate cancer.

Investors

Technology: Canada
Industry: Reproductive Health & Contraception
Headquarters: Edmonton, Alberta, Canada
Founded Date: 2017-01-01
Employees Number: 11-50
Investors Number: 1
Total Funding: $2,231,479
Last Funding Date: 2017-11-15
Last Funding Type: Venture - Series Unknown

Visit Website
info@nanosticsdx.com
https://twitter.com/nanostics
Register and Claim Ownership